Literature DB >> 15006854

The ocular hypertension treatment study: intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease?

Alan L Robin1, Kevin D Frick, Joanne Katz, Donald Budenz, James M Tielsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15006854     DOI： 10.1001/archopht.122.3.376

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  4 in total

Review 1.  Screening for primary open-angle glaucoma in the primary care setting: an update for the US preventive services task force.

Authors:  Craig Fleming; Evelyn P Whitlock; Tracy Beil; Barbara Smit; Russell P Harris
Journal:  Ann Fam Med       Date:  2005 Mar-Apr       Impact factor: 5.166

2.  Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002.

Authors:  Joshua D Stein; Frank A Sloan; Paul P Lee
Journal:  Am J Ophthalmol       Date:  2007-05       Impact factor: 5.258

3.  Incorporating mortality risk into estimates of 5-year glaucoma risk.

Authors:  Beth Ann Griffin; Marc N Elliott; Anne L Coleman; Eric M Cheng
Journal:  Am J Ophthalmol       Date:  2009-10-02       Impact factor: 5.258

4.  Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields.

Authors:  Pamela A Sample; Catherine Boden; Zuohua Zhang; John Pascual; Te-Won Lee; Linda M Zangwill; Robert N Weinreb; Jonathan G Crowston; Esther M Hoffmann; Felipe A Medeiros; Terrence Sejnowski; Michael Goldbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.